|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02329 GLORY HEALTH
Nominal 
0.099 -0.010 (-9.174%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 139,540 | -56.956% | 1,035,613 | 2,705,332 | 2,506,285 | 3,904,672 |
| Cost of Sales | (31,925) | -90.017% | (1,343,700) | (2,149,768) | (2,556,565) | (3,791,155) |
| Gross Profit | 107,615 | 2363.149% | (308,087) | 555,564 | (50,280) | 113,517 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | 47,884 | (498,940) | 263,500 | 20,059 | |
| Change in FV & Impairment on Others | -- | -- | (219,133) | (59,642) | (59,264) | (88,075) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (69,929) | (62,315) | 42,027 | |
| Profit / (Loss) before Taxation | (72,601) | -61.451% | (1,901,628) | (1,436,308) | (655,460) | (1,090,344) | |
| Taxation | (199,479) | -- | 132,242 | 20,805 | 61,957 | 95,051 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (53,027) | -3.867% | (53,086) | 175,074 | 29,532 | 82,511 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (325,107) | 44.377% | (1,822,472) | (1,240,429) | (563,971) | (912,782) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 117,037 | 200.418% | 783,538 | 996,117 | 488,055 | 651,128 |
| Depreciation & Amortisation | 23,091 | -1.749% | 51,960 | 89,651 | 95,281 | 123,027 |
| Directors' Emoluments | -- | -- | 5,175 | 6,978 | 6,316 | 8,783 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Disclaimer | Disclaimer | Disclaimer | Disclaimer |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -7.310 | 44.181% | -41.000 | -28.000 | -13.000 | -21.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.017 | 0.153 | 0.115 | 0.136 |
| NBV per share ($) | 1.751 | -- | 1.824 | 2.234 | 2.513 | 2.640 |
| Remarks: | Real time quote last updated: 14/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -325,107 |
| %Change | 44.377% |
| EPS / (LPS) | RMB -0.073 |
| NBV Per Share (¥) | RMB 1.751 |